Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF"

Circulation. 2023 Mar 14;147(11):920-921. doi: 10.1161/CIRCULATIONAHA.122.061155. Epub 2023 Mar 13.

Authors

Luca Monzo^{1

2}, Vojtech Melenovsky¹

Affiliations

¹ Institute for Clinical and Experimental Medicine, Prague, Czech Republic (L.M., V.M.).
² Sapienza University, Rome, Italy (L.M.).

PMID: 36913496
DOI: 10.1161/CIRCULATIONAHA.122.061155

No abstract available

Publication types

Letter
Comment

MeSH terms

Benzhydryl Compounds* / pharmacology
Benzhydryl Compounds* / therapeutic use
Glucosides / therapeutic use
Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Stroke Volume
Ventricular Function, Left

Substances

dapagliflozin
Benzhydryl Compounds
Glucosides